Fundraising FoxAmbros Therapeutics
acquired by Werewolf TherapeuticsSan Diego, US · 10 known investors
Find your way into Ambros Therapeutics
Acquired by Werewolf Therapeutics August 2026 · $500M (Ambros valued at $500 million pre-money; $150 million concurrent private placement) · source ↗
Ambros Therapeutics is a clinical-stage biotechnology company developing medicines for diseases with high unmet medical need, with a lead program targeting complex regional pain syndrome type 1 (CRPS-1), a rare condition typically following limb injury. Its investigational treatment is neridronate, a bisphosphonate, being evaluated in a Phase 3 pivotal trial (CRPS-RISE).
Founders & leadership
Investors · 10
How we know: LifeSci Venture Partners's portfolio page · Not right? Tell us
How we know: RA Capital's portfolio page · cooley.com · Not right? Tell us
How we know: cooley.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements$125M disclosed across 1 round · 2025
- $125MSeries ADec 2025 · 4 sources
Enavate Sciences (lead), Patient Square Capital (lead), RA Capital Management (lead), Abiogen Pharma, Adage Capital Partners LP, Arkin Bio, Balyasny Asset Management, Janus Henderson Investors, Transhuman Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ambros Therapeutics do?
- Ambros Therapeutics is a clinical-stage biotechnology company developing medicines for diseases with high unmet medical need, with a lead program targeting complex regional pain syndrome type 1 (CRPS-1), a rare condition typically following limb injury. Its investigational treatment is neridronate, a bisphosphonate, being evaluated in a Phase 3 pivotal trial (CRPS-RISE).
- Who are Ambros Therapeutics's investors?
- Ambros Therapeutics's investors include LifeSci Venture Partners, RA Capital, BAM Elevate, Janus Henderson Investors, Patient Square Capital.
- How much funding has Ambros Therapeutics raised?
- Ambros Therapeutics has disclosed $125M raised across 1 round.
- Who acquired Ambros Therapeutics?
- Ambros Therapeutics was acquired by Werewolf Therapeutics.
- Where is Ambros Therapeutics headquartered?
- Ambros Therapeutics is headquartered in San Diego, US.